Coronary Stents Market Report by Type (Drug-eluting Stents, Bare-metal Coronary Stents, Bioabsorbable Stents), Biomaterial (Metallic Biomaterial, Polymeric Biomaterial, Natural Biomaterial), Mode of Delivery (Balloon-expandable Stents, Self-expanding Sten

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,999	135 Pages	IMARC Services Pvt. Ltd.	August, 2024	IMRC19103540

Best Price Guarantee
Price	from $2,999
Length	135 Pages
Publisher	IMARC Services Pvt. Ltd.
Published Date	August, 2024
SKU	IMRC19103540

Coronary Stents Market Report by Type (Drug-eluting Stents, Bare-metal Coronary Stents, Bioabsorbable Stents), Biomaterial (Metallic Biomaterial, Polymeric Biomaterial, Natural Biomaterial), Mode of Delivery (Balloon-expandable Stents, Self-expanding Stents), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Region 2024-2032

The global coronary stents market size reached US$ 11.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 18.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5.46% during 2024-2032.

Coronary stents are small, self-expanding tubular metallic devices introduced inside narrow coronary arteries to keep them open after a balloon angioplasty procedure. These stents are coated with a medication, which is slowly released to prevent the walls of arteries from plaque buildup and re-narrowing. They also alleviate heart disease symptoms, such as chest pain and shortness of breath, and allow normal flow of blood and oxygen to the heart. As they are minimally invasive (MI) and require shorter recovery time, coronary stents are gaining traction over coronary artery bypass surgeries around the world.

Coronary Stents Market Trends:

The growing incidence of diabetes, obesity and high blood pressure (BP) is escalating the risk of atherosclerosis disease. This, along with the rising geriatric population, which is more likely to develop cardiovascular diseases (CVDs), represents one of the significant factors impelling the growth of the coronary stent market. Apart from this, the growing popularity of minimally invasive surgeries (MIS) is resulting in the increasing adoption of coronary stents that involve small incision wounds, short hospital stays and fast recovery. Other factors contributing to the market growth include the development of bifurcated stents, improving healthcare infrastructure and rising manufacturing of products using biodegradable materials. Furthermore, the leading market players are introducing advanced products, which is anticipated to drive the market in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global coronary stents market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, biomaterial, mode of delivery and end user.

Breakup by Type:

Drug-eluting Stents
Bare-metal Coronary Stents
Bioabsorbable Stents

Breakup by Biomaterial:

Metallic Biomaterial
Polymeric Biomaterial
Natural Biomaterial

Breakup by Mode of Delivery:

Balloon-expandable Stents
Self-expanding Stents

Breakup by End User:

Hospitals
Ambulatory Surgical Centers
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corporation, Elixir Medical Corporation, Lepu Medical Technology (Beijing) Co. Ltd., Medtronic plc, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, Terumo Corporation and Translumina GmbH.

Key Questions Answered in This Report

1. What was the size of the global coronary stents market in 2023?

2. What is the expected growth rate of the global coronary stents market during 2024-2032?

3. What are the key factors driving the global coronary stents market?

4. What has been the impact of COVID-19 on the global coronary stents market?

5. What is the breakup of the global coronary stents market based on the type?

6. What is the breakup of the global coronary stents market based on biomaterial?

7. What is the breakup of the global coronary stents market based on the mode of delivery?

8. What is the breakup of the global coronary stents market based on the end user?

9. What are the key regions in the global coronary stents market?

10. Who are the key players/companies in the global coronary stents market?

1 Preface
2 Scope and Methodology: 2.1 Objectives of the Study; 2.2 Stakeholders; 2.3 Data Sources; 2.3.1 Primary Sources; 2.3.2 Secondary Sources; 2.4 Market Estimation; 2.4.1 Bottom-Up Approach; 2.4.2 Top-Down Approach; 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction: 4.1 Overview; 4.2 Key Industry Trends
5 Global Coronary Stents Market: 5.1 Market Overview; 5.2 Market Performance; 5.3 Impact of COVID-19; 5.4 Market Forecast
6 Market Breakup by Type: 6.1 Drug-eluting Stents; 6.1.1 Market Trends; 6.1.2 Market Forecast; 6.2 Bare-metal Coronary Stents; 6.2.1 Market Trends; 6.2.2 Market Forecast; 6.3 Bioabsorbable Stents; 6.3.1 Market Trends; 6.3.2 Market Forecast
7 Market Breakup by Biomaterial: 7.1 Metallic Biomaterial; 7.1.1 Market Trends; 7.1.2 Market Forecast; 7.2 Polymeric Biomaterial; 7.2.1 Market Trends; 7.2.2 Market Forecast; 7.3 Natural Biomaterial; 7.3.1 Market Trends; 7.3.2 Market Forecast
8 Market Breakup by Mode of Delivery: 8.1 Balloon-expandable Stents; 8.1.1 Market Trends; 8.1.2 Market Forecast; 8.2 Self-expanding Stents; 8.2.1 Market Trends; 8.2.2 Market Forecast
9 Market Breakup by End User: 9.1 Hospitals; 9.1.1 Market Trends; 9.1.2 Market Forecast; 9.2 Ambulatory Surgical Centers; 9.2.1 Market Trends; 9.2.2 Market Forecast; 9.3 Others; 9.3.1 Market Trends; 9.3.2 Market Forecast
10 Market Breakup by Region: 10.1 North America; 10.1.1 United States; 10.1.1.1 Market Trends; 10.1.1.2 Market Forecast; 10.1.2 Canada; 10.1.2.1 Market Trends; 10.1.2.2 Market Forecast; 10.2 Asia-Pacific; 10.2.1 China; 10.2.1.1 Market Trends; 10.2.1.2 Market Forecast; 10.2.2 Japan; 10.2.2.1 Market Trends; 10.2.2.2 Market Forecast; 10.2.3 India; 10.2.3.1 Market Trends; 10.2.3.2 Market Forecast; 10.2.4 South Korea; 10.2.4.1 Market Trends; 10.2.4.2 Market Forecast; 10.2.5 Australia; 10.2.5.1 Market Trends; 10.2.5.2 Market Forecast; 10.2.6 Indonesia; 10.2.6.1 Market Trends; 10.2.6.2 Market Forecast; 10.2.7 Others; 10.2.7.1 Market Trends; 10.2.7.2 Market Forecast; 10.3 Europe; 10.3.1 Germany; 10.3.1.1 Market Trends; 10.3.1.2 Market Forecast; 10.3.2 France; 10.3.2.1 Market Trends; 10.3.2.2 Market Forecast; 10.3.3 United Kingdom; 10.3.3.1 Market Trends; 10.3.3.2 Market Forecast; 10.3.4 Italy; 10.3.4.1 Market Trends; 10.3.4.2 Market Forecast; 10.3.5 Spain; 10.3.5.1 Market Trends; 10.3.5.2 Market Forecast; 10.3.6 Russia; 10.3.6.1 Market Trends; 10.3.6.2 Market Forecast; 10.3.7 Others; 10.3.7.1 Market Trends; 10.3.7.2 Market Forecast; 10.4 Latin America; 10.4.1 Brazil; 10.4.1.1 Market Trends; 10.4.1.2 Market Forecast; 10.4.2 Mexico; 10.4.2.1 Market Trends; 10.4.2.2 Market Forecast; 10.4.3 Others; 10.4.3.1 Market Trends; 10.4.3.2 Market Forecast; 10.5 Middle East and Africa; 10.5.1 Market Trends; 10.5.2 Market Breakup by Country; 10.5.3 Market Forecast
11 SWOT Analysis: 11.1 Overview; 11.2 Strengths; 11.3 Weaknesses; 11.4 Opportunities; 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis: 13.1 Overview; 13.2 Bargaining Power of Buyers; 13.3 Bargaining Power of Suppliers; 13.4 Degree of Competition; 13.5 Threat of New Entrants; 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape: 15.1 Market Structure; 15.2 Key Players; 15.3 Profiles of Key Players; 15.3.1 Abbott Laboratories; 15.3.1.1 Company Overview; 15.3.1.2 Product Portfolio; 15.3.1.3 Financials; 15.3.1.4 SWOT Analysis; 15.3.2 B. Braun Melsungen AG; 15.3.2.1 Company Overview; 15.3.2.2 Product Portfolio; 15.3.2.3 SWOT Analysis; 15.3.3 Biotronik SE & Co. KG; 15.3.3.1 Company Overview; 15.3.3.2 Product Portfolio; 15.3.3.3 SWOT Analysis; 15.3.4 Boston Scientific Corporation; 15.3.4.1 Company Overview; 15.3.4.2 Product Portfolio; 15.3.4.3 Financials; 15.3.4.4 SWOT Analysis; 15.3.5 Elixir Medical Corporation; 15.3.5.1 Company Overview; 15.3.5.2 Product Portfolio; 15.3.6 Lepu Medical Technology (Beijing) Co. Ltd.; 15.3.6.1 Company Overview; 15.3.6.2 Product Portfolio; 15.3.6.3 Financials; 15.3.7 Medtronic plc; 15.3.7.1 Company Overview; 15.3.7.2 Product Portfolio; 15.3.7.3 Financials; 15.3.7.4 SWOT Analysis; 15.3.8 Meril Life Sciences Pvt. Ltd.; 15.3.8.1 Company Overview; 15.3.8.2 Product Portfolio; 15.3.9 MicroPort Scientific Corporation; 15.3.9.1 Company Overview; 15.3.9.2 Product Portfolio; 15.3.10 Terumo Corporation; 15.3.10.1 Company Overview; 15.3.10.2 Product Portfolio; 15.3.10.3 Financials; 15.3.10.4 SWOT Analysis; 15.3.11 Translumina GmbH; 15.3.11.1 Company Overview; 15.3.11.2 Product Portfolio